Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Value of CD26 Positive Stem Cell Marker in Patients With Classical Myeloproliferative Neoplasms

NCT04312607 is registered in ClinicalTrials.gov with Safaa AA Khaled as lead sponsor.

NCT NCT04312607
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04312607 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Value of CD26 Positive Stem Cell Marker in Patients With Classical Myeloproliferative Neoplasms
Lead sponsor
Safaa AA Khaled
Phase
Observational
Overall status
Unknown status
Start date
August 1, 2020
Completion date
March 1, 2022
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

myeloproliferative neoplasm